CPHI North America 2023 brought together the entire pharmaceutical supply chain under one roof, providing an unparalleled opportunity for learning, networking, and sourcing new opportunities at the core of the sector. Held at the Philadelphia Convention Centre, Vantage Hemp Co. saw a diverse group of stakeholders,...
[vc_row][vc_column][vc_column_text] Leading producer reinforces its commitment to bringing the highest quality ingredients to clinical trials and the food additive, dietary supplement, and pharmaceutical industries Greeley, Colorado, April 4, 2023 - Vantage Hemp Co. (“Vantage” or the “Company”) announces that it has submitted a Drug Master File (DMF)...
In today’s landscape, the asset-light business model has become increasingly popular, and for good reason. An asset-light model allows businesses to focus on their core competencies while outsourcing other aspects of their operations to trusted partners. This approach has proven successful for many industries, including...
Cannabidiol (CBD) has taken the wellness industry by storm. CBD is a natural compound found in the Cannabis sativa L. plant (cannabis) that has gained popularity in recent years due to its potential therapeutic benefits, versatility, and non-intoxicating effects. Part of the attraction to CBD is...
Hemp-derived Cannabinoids – A New Era The 2018 Farm Bill succeeded in federally legalizing the cultivation of ‘hemp’ by removing it from DEA (Drug Enforcement Administration) oversight. Under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, the FDA has maintained authority...
Pharmaceutical-grade CBD producer shows commitment to increasing white label format capabilities Industry leader, Vantage Hemp Co. (“Vantage” or the “Company”), announces softgel capabilities in response to meeting client and consumer demands. As the Company expands its white label and contract manufacturing services, its softgels achieve the highest global...
Manufacturer of pharmaceutical-grade CBD products to meet global Cannabinoid demand
Studies have demonstrated CBD’s proficiency to treat inflammation with the ability to remedy a number of physical and mental illnesses. Compounds with anti-inflammatory properties are highly prized in both wellness and medical markets, and CBD has the added benefits of antibacterial and antiviral attributes. With the popularity of tinctures, topicals and capsules promoting increased consumer accessibility and adoption, the global CBD market is expected to surpass $13 billion in revenue by 2028. The EU cosmetic ingredient database determined that cannabinoids can be used in cleansers and conditioners, with hemp-based CBD oil particularly revered as it rejuvenates damaged skin.